A Study of Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients (3G)

Clinical Trial ID NCT01100801

PubWeight™ 3.67‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01100801

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy. Gastroenterology 2011 2.36
2 Trial watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology 2012 1.33
3 Alternate-day oral therapy with TS-1 for advanced gastric cancer. Int J Clin Oncol 2004 0.97
4 Chemotherapy for advanced gastric cancer: review of global and Japanese status. Gastrointest Cancer Res 2007 0.86
Next 100